The Westin Beijing Financial Street-Tourism news

Tourism News

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives2026-04-01
XI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tiger...
BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives2026-04-01
XI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tiger...
BLUETTI Launches EnergyPro 13K Energy Storage System For Whole-Home Backup2026-04-01
LOS ANGELES, March 31, 2026 /PRNewswire/ -- BLUETTI, a global leader in clean energy storage, has unveiled its next-generation whole-home backup solution, the EnergyPro 13K Energy Storage System (EP13K ESS), to address growing concerns over grid instability and soaring electricity costs. This all-in-one, scalable system integrates a hybrid inverter, modular ...
BLUETTI Launches EnergyPro 13K Energy Storage System For Whole-Home Backup2026-04-01
LOS ANGELES, March 31, 2026 /PRNewswire/ -- BLUETTI, a global leader in clean energy storage, has unveiled its next-generation whole-home backup solution, the EnergyPro 13K Energy Storage System (EP13K ESS), to address growing concerns over grid instability and soaring electricity costs. This all-in-one, scalable system integrates a hybrid inverter, modular ...
Why Does Some Green Tea Taste Bitter: iTeaworld Introduces an Easier Way to Discover Chinese Green Tea2026-04-01
SHENZHEN, China, March 31, 2026 /PRNewswire/ -- For many U.S. consumers, getting started with Chinese green tea can feel surprisingly difficult. With unfamiliar names, origins, and flavor profiles, many are unsure where to begin. As a result, some consumers end up choosing teas that taste overly bitter or flat, reinforcing the impression that "green tea...
Why Does Some Green Tea Taste Bitter: iTeaworld Introduces an Easier Way to Discover Chinese Green Tea2026-04-01
SHENZHEN, China, March 31, 2026 /PRNewswire/ -- For many U.S. consumers, getting started with Chinese green tea can feel surprisingly difficult. With unfamiliar names, origins, and flavor profiles, many are unsure where to begin. As a result, some consumers end up choosing teas that taste overly bitter or flat, reinforcing the impression that "green tea...
Building on Trust, Embracing Change2026-04-01
Phoenix TV Celebrates 30th Anniversary in Hong Kong HONG KONG, March 31, 2026 /PRNewswire/ -- On March 31, Phoenix TV holds the Phoenix Satellite TV's 30th Anniversary Gala at its headquarters in Tai Po, Hong Kong. The event is attended by officiating guests including John Lee, Hong Kong Chief Executive; Xu Zhengzhong, Chairman o...
Building on Trust, Embracing Change2026-04-01
Phoenix TV Celebrates 30th Anniversary in Hong Kong HONG KONG, March 31, 2026 /PRNewswire/ -- On March 31, Phoenix TV holds the Phoenix Satellite TV's 30th Anniversary Gala at its headquarters in Tai Po, Hong Kong. The event is attended by officiating guests including John Lee, Hong Kong Chief Executive; Xu Zhengzhong, Chairman o...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-22026-04-01
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection, have successfully met their pre-specified primary endpoints. After 26 weeks of tr...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-22026-04-01
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection, have successfully met their pre-specified primary endpoints. After 26 weeks of tr...

The Westin Beijing Financial Street

Tourism News

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives2026-04-01

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives2026-04-01

BLUETTI Launches EnergyPro 13K Energy Storage System For Whole-Home Backup2026-04-01

BLUETTI Launches EnergyPro 13K Energy Storage System For Whole-Home Backup2026-04-01

Why Does Some Green Tea Taste Bitter: iTeaworld Introduces an Easier Way to Discover Chinese Green Tea2026-04-01

Why Does Some Green Tea Taste Bitter: iTeaworld Introduces an Easier Way to Discover Chinese Green Tea2026-04-01

Building on Trust, Embracing Change2026-04-01

Building on Trust, Embracing Change2026-04-01

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-22026-04-01

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-22026-04-01

The Westin Beijing Financial Street